Continuing Education
Updates in Non-Small Cell Lung Cancer
Best Suited For: Pharmacist, Pharmacy Technician
CE Credits: 1 hours
Activity Description
The goal of this activity is to provide pharmacists, pharmacy technicians, and other healcare providers a general overview of non-small cell lung cancer and highlight some recent updates to guidelines in the past year. The program will review data for recently approved therapy indications that have been incorporated into guidelines, along with a review of existing therapies that may have a similar place in guidelines. Audience members will gain better knowledge and understanding of recent therapy updates and their place in clinical practice.
CE Credit: 1 hour
Fee: This activity does not require payment to register.
Learning Objectives
- Review general disease settings and their treatment modalities for Non-Small Cell Lung Cancer (NSCLC).
- Identify recent therapy approvals and their incorporation into current guidelines for NSCLC.
- Recognize recently approved therapies targeted against biomarkers without previous treatments in NSCLC.
Obtaining CE Credit
To receive credit, you must and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email from LecturePanda You may also use this page to obtain CE credit. After following the link on this page to in order to receive credit:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Watching the CE video (if it is an enduring or on-demand CE activity) to its entirety
- Submitting the CE Code (disclosed towards the end of all CE activities)
- Completing all listed evaluations and CE assessments.
Credit requirements must be completed before the date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted will be viewable in your CPE Monitor profile within 24 hours.
